会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明申请
    • METHODS FOR THE MODULATION OF ANGIOGENESIS
    • 血管生成调节方法
    • US20110135632A1
    • 2011-06-09
    • US12999746
    • 2009-06-19
    • Donald E. IngberAkiko Mammoto
    • Donald E. IngberAkiko Mammoto
    • A61K39/395A61K31/7088A61K38/00A61P35/00A61P3/10A61P27/02A61P19/02A61P25/28A61P3/04A61P17/06A61P9/00A61P17/02
    • C12N15/113A61K31/7088A61K45/06C12N2310/14
    • The present invention relates to methods and compositions of promoting or inhibiting capillary endothelial (CE) cell migration, promoting or inhibiting the formation of CE networks and promoting or inhibiting angiogenesis, and uses thereof. In particular, the present invention relates to methods and compositions for promoting capillary endothelial (CE) cell migration, promoting the formation of CE networks and promoting angiogenesis, and uses thereof for the purposes of treating angiogenesis-related disorders characterized by loss or decreased angiogenesis, such as ischemic injury and the like. One aspect of the invention related to use of at least one pro-angiogenic agent selected from at least one of an p190RhoGAP inhibitor, a TFII-I inhibitor or a GATA-2 activator for promoting the formation of CE networks and promoting angiogenesis, and uses thereof for the purposes of treating angiogenesis-related disorders characterized by loss or decreased angiogenesis. Another aspect of the invention related to use of at least one anti-angiogenic agent selected from at least one of an p190RhoGAP activator, a TFII-I activator or a GATA-2 inhibitor for inhibiting the formation of CE networks and inhibiting angiogenesis, and uses thereof for the purposes of treating angiogenesis-related disorders characterized by uncontrolled or elevated angiogenesis.
    • 本发明涉及促进或抑制毛细血管内皮细胞迁移,促进或抑制CE网络形成和促进或抑制血管发生的方法和组合物及其用途。 特别地,本发明涉及用于促进毛细血管内皮细胞迁移,促进CE网络的形成和促进血管发生的方法和组合物及其用于治疗以血管生成减少或减少为特征的血管生成相关病症的用途, 例如缺血性损伤等。 本发明的一个方面涉及使用选自p190RhoGAP抑制剂,TFII-1抑制剂或GATA-2激活剂中的至少一种的至少一种促血管生成剂来促进CE网络的形成和促进血管生成,以及使用 其用于治疗以血管生成丧失或减少为特征的血管生成相关病症的目的。 本发明的另一方面涉及使用选自p190RhoGAP激活剂,TFII-1激活剂或GATA-2抑制剂中的至少一种的至少一种抗血管生成剂来抑制CE网络的形成和抑制血管生成,以及使用 以治疗以不受控制或升高的血管发生为特征的血管发生相关疾病的目的。
    • 37. 发明授权
    • Methods for the modulation of angiogenesis
    • 调节血管发生的方法
    • US08722638B2
    • 2014-05-13
    • US12999746
    • 2009-06-19
    • Donald E. IngberAkiko Mammoto
    • Donald E. IngberAkiko Mammoto
    • C12N15/11A61K48/00C07H21/02C07H21/04
    • C12N15/113A61K31/7088A61K45/06C12N2310/14
    • The present invention relates to methods and compositions for promoting or inhibiting capillary endothelial (CE) cell migration, promoting or inhibiting the formation of CE networks and promoting or inhibiting angiogenesis. Some embodiments relate to methods and compositions for treating angiogenesis-related disorders characterized by loss or decreased angiogenesis. One aspect relates to the use of at least one pro-angiogenic agent selected from at least one of an p190RhoGAP inhibitor, a TFII-I inhibitor or a GATA-2 activator for promoting the formation of CE networks and angiogenesis, and methods for treating angiogenesis-related disorders characterized by loss or decreased angiogenesis. Another aspect of the invention related to use of at least one anti-angiogenic agent selected from at least one of an p190RhoGAP activator, a TFII-I activator or a GATA-2 inhibitor for inhibiting the formation of CE networks and inhibiting angiogenesis, and methods for treating angiogenesis-related disorders characterized by uncontrolled or elevated angiogenesis.
    • 本发明涉及用于促进或抑制毛细血管内皮细胞迁移,促进或抑制CE网络形成和促进或抑制血管发生的方法和组合物。 一些实施方案涉及用于治疗以血管生成减少或减少为特征的血管生成相关病症的方法和组合物。 一方面涉及使用至少一种选自p190RhoGAP抑制剂,TFII-1抑制剂或GATA-2激活剂中的至少一种的促血管生成剂来促进CE网络和血管生成的形成,以及用于治疗血管发生的方法 以血管生成减少或减少为特征的相关疾病。 本发明的另一方面涉及使用选自p190RhoGAP激活剂,TFII-1激活剂或GATA-2抑制剂中的至少一种的至少一种抗血管生成剂来抑制CE网络的形成和抑制血管生成,以及方法 用于治疗以不受控制或升高的血管发生为特征的血管发生相关疾病。